scispace - formally typeset
Search or ask a question
Institution

Applied Biosystems

About: Applied Biosystems is a based out in . It is known for research contribution in the topics: Mass spectrometry & Nucleic acid. The organization has 1521 authors who have published 1579 publications receiving 285423 citations.


Papers
More filters
Journal ArticleDOI
Tim Geiser1
TL;DR: Recent interest in anti-HIV (anti-rev) phosphorothioate analogues of DNA has prompted us to develop scale-up methodology for routinely producing gram amounts of such analogues, and results and considerations given to producing clinical and commercial quantities were discussed.
Abstract: The therapeutic potential of antisense oligonucleotides will heavily depend on a balance of two factors: pharmacologic effectiveness and cost of production. Pharmacologic optimization will be achieved to a limited degree in in vitro systems, but substantial progress can only be made in the context of appropriate in vivo models. The quantities of synthetic oligonucleotides required for modest in vivo testing are several thousandfold greater than can be produced by conventional DNA synthesis technology and 10(5)-10(7)-fold greater for preclinical and clinical evaluation. Cost-effective synthesis and purification cannot be achieved by extrapolating current technologies to scales commensurate with these quantities. Recent interest in anti-HIV (anti-rev) phosphorothioate analogues of DNA (approximately 28-mers) has prompted us to develop scale-up methodology for routinely producing gram amounts of such analogues. These results and considerations given to producing clinical and commercial quantities were discussed.

18 citations

Patent
20 Jun 1988
TL;DR: In this paper, an apparatus and process are used to cyclicly degrade a peptide to be sequenced, arriving at a set of amino acid residues for each cycle, and the amount of each amino acid residue is quantitatively measured in each set, then a background level is fit to each cycle to obtain a background fit.
Abstract: An apparatus and process are used to cyclicly degrade a peptide to be sequenced, arriving at a set of amino acid residues for each cycle. The amount of each amino acid residue is quantitatively measured in each set, then a background level is fit to each cycle to obtain a background fit. A measure of dispersion is then calculated for the background fit, and the measured amounts of amino acid residues in each cycle are normalized relative to the background fit. The largest normalized background-corrected residue amount in each cycle then provides a sequence assignment that can be used for further correction steps if desired.

18 citations

Journal ArticleDOI
TL;DR: Because of its simplicity, speed, and potential for automation and miniaturization, TaqMan is an excellent candidate for investigation of genetic variation in clinical, research, and forensic settings.
Abstract: Background: Variations within the human genome play important roles in human disease. To study variations related to susceptibility to AIDS, we have developed 5′ nuclease assays that eliminate post-PCR molecular biology steps. Methods: TaqMan assays based on the 5′ nuclease activity of Taq polymerase and fluorescent resonance energy transfer were developed to score alleles at the biallelic loci CCR5 - + /Δ 32 , CCR2-V64I and SDF1-G801A . For each assay, 72 samples were analyzed. Data collection and analysis were performed on the Prism 7700 Sequence Detection System. For comparison with gel electrophoresis methods, each locus was also scored on a subset of 24 samples, using restriction enzymes or single-strand conformational polymorphism (SSCP). Results: Clear allelic discrimination was obtained on each of the 72 samples for all three TaqMan assays. The TaqMan scores for the subset of 24 samples were concordant with the restriction enzyme and SSCP scores. Conclusions: Because of its simplicity, speed, and potential for automation and miniaturization, TaqMan is an excellent candidate for investigation of genetic variation in clinical, research, and forensic settings.

18 citations

Patent
03 Nov 2005
TL;DR: In this article, the authors present methods and optical systems for scanning of a target sample, including methods and systems using a low mass scan head and methods and methods for conducting a scanned optically transduced assay where the scanning includes at least one first relative angular motion and at least 1 second angular motion or at least linear motion.
Abstract: Methods and optical systems for scanning of a target sample, including methods and systems using a low mass scan head and methods and systems for conducting a scanned optically transduced assay where the scanning includes at least one first relative angular motion and at least one second angular motion or at least one linear motion. The present invention also relates to methods and systems for performing sample assays, and for producing and measuring optical responses and signatures.

18 citations

Journal ArticleDOI
TL;DR: Very low levels of MDR1 in CEM Dox1 cells could be detected only by QPCR, which was found to be more reproducible, accurate and sensitive than 32P-PCR.
Abstract: The MDR1 gene is involved in drug resistance in man y hematopoietic and solid tumors The Quantitative PCR System 5000 ™ (QPCR-5000; Perkin-Elmer) is a new instrument system tha t uses electrochemiluminescence to automatically quantitate pol y merase chain reaction (PCR) products A comparative study b e tween radioactively labeled PCR ( 3 2 P-PCR) and QPCR was pe r formed to analyze the MDR1 gene expression in the drug-resistan t (Doxorubicin) cell lines Dox40, Dox6, the parental cell line 8226/S , CEM Dox1 and three acute myeloid leukemia (AML) patient sam ples Using the Dox40 and Dox6 resistant cell lines, we compared the sensitivities of QPCR and 3 2 P-PCR A strong signal was ob tained from QPCR at 20 to 25 cycles (which is in the linear range fo r quantitation), while a weak signal was obtained using 3 2 P-PCR a t the same cycle number Dilution experiments gave better precision with the QPCR than with the radioactive method AML samples wer e studied with the MDR1-specific MAbs MRK16 and 4E3, and the e f flux function was analyzed using Rh-123 retention in the absence o r presence of verapamil The three samples showed high (D = 079) , medium (D = 052) and negative (D = 008) p-glycoprotein (P-gp ) levels and correlated with efflux function The MDR1 / β 2 -M mRNA ratios for 3 2 P-PCR were 041, 040 and 012, respectively, and wer e 0127, 0097 and 0028, respectively, for QPCR There were signif i cant differences between the samples with high and medium P-gp levels comparing the two methods Very low levels of MDR1 in CEM Dox1 cells could be detected only by QPCR In conclusion, QPCR was found to be more reproducible, accurate and sensitive than

18 citations


Authors

Showing all 1521 results

NameH-indexPapersCitations
Richard A. Gibbs172889249708
Friedrich C. Luft113109547619
Alexander N. Glazer7120821068
Vineet Bafna6823642574
Kevin R. Coombes6330823592
Darryl J. Pappin6117029409
Mark D. Johnson6028916103
György Marko-Varga5640912600
Paul Thomas5612844810
Gerald Zon5525611126
Michael W. Hunkapiller5113029756
Bjarni V. Halldorsson5114513180
David H. Hawke501579824
Ellson Y. Chen507128836
Sridhar Hannenhalli4916221959
Network Information
Related Institutions (5)
Genentech
17.1K papers, 1.4M citations

88% related

National Institutes of Health
297.8K papers, 21.3M citations

86% related

Scripps Research Institute
32.8K papers, 2.9M citations

86% related

Hoffmann-La Roche
43K papers, 1.6M citations

85% related

Wellcome Trust Sanger Institute
9.6K papers, 1.2M citations

85% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20182
20171
20164
20152
20147
201313